New Zealand approves third Covid vaccine Novavax for those over 18

New Zealanders will soon be able to access a third type of Novavax vaccine following the government's confirmation.

Topics
Coronavirus | Coronavirus Vaccine | Omicron

IANS  |  Wellington 

FILE - This Wednesday, Oct. 7, 2020 file photo shows a vial of the Phase 3 Novavax coronavirus vaccine ready for use in a trial at St. George's University hospital in London. (Photo: AP)
Novavax coronavirus vaccine (Photo: AP)

New Zealanders will soon be able to access a third type of Novavax vaccine following the government's confirmation.

Covid Response Minister Chris Hipkins said on Tuesday that Novavax will soon be available to New Zealanders aged 18 and over, Xinhua news agency reported.

"Novavax is a protein-based Covid vaccine and while the Pfizer Covid vaccine remains the preferred vaccine of most New Zealanders, for some people, the arrival of Novavax will be the extra incentive required to get vaccinated against Covid," Hipkins said in a statement.

is already one of the most highly vaccinated countries in the world with 95 per cent of people aged 12 and over being vaccinated, Hipkins said.

The first doses are anticipated to arrive in this month, and officials are working with Novavax to confirm the delivery schedule and rollout start date, he said.

--IANS

int/sks/dpb

(Only the headline and picture of this report may have been reworked by the Business Standard staff; the rest of the content is auto-generated from a syndicated feed.)

Dear Reader,


Business Standard has always strived hard to provide up-to-date information and commentary on developments that are of interest to you and have wider political and economic implications for the country and the world. Your encouragement and constant feedback on how to improve our offering have only made our resolve and commitment to these ideals stronger. Even during these difficult times arising out of Covid-19, we continue to remain committed to keeping you informed and updated with credible news, authoritative views and incisive commentary on topical issues of relevance.
We, however, have a request.

As we battle the economic impact of the pandemic, we need your support even more, so that we can continue to offer you more quality content. Our subscription model has seen an encouraging response from many of you, who have subscribed to our online content. More subscription to our online content can only help us achieve the goals of offering you even better and more relevant content. We believe in free, fair and credible journalism. Your support through more subscriptions can help us practise the journalism to which we are committed.

Support quality journalism and subscribe to Business Standard.

Digital Editor

Read our full coverage on Coronavirus
First Published: Tue, March 01 2022. 12:39 IST
RECOMMENDED FOR YOU